Exponent Analyst Price Targets - Benzinga

Exponent Inc

EXPONASDAQ

Trade with Public

Trade with Public

$65.42

0.891.38%

가까이에: Sep 30, 5:00 PM EST

$65.66

0.240.37%

시간외: 4:01 PM EST

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

Exponent Analyst Price Targets

Wall Street analyst price targets and consensus rating for Exponent (EXPO).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

3Buy

1Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$94Upside to Avg. PT+43.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 31, 2026	UBS	Joshua Chan	PT Cut	Neutral	$75→$72
Jul 31, 2026	JP Morgan	Tomohiko Sano	PT Raise	Overweight	$80→$90
May 15, 2026	JP Morgan	Tomohiko Sano	PT Cut	Overweight	$95→$80
May 1, 2026	UBS	Joshua Chan	PT Cut	Neutral	$85→$75
Mar 26, 2026	JP Morgan	Tomohiko Sano	PT Cut	Overweight	$100→$95
Jan 26, 2026	JP Morgan	Tomohiko Sano	Initiate	Overweight	$100
Dec 15, 2025	UBS	Joshua Chan	PT Raise	Neutral	$76→$81
Nov 17, 2025	William Blair	Andrew Nicholas	Upgrade	Market Perform→Outperform	—
Jul 26, 2024	Truist Securities	Tobey Sommer	PT Raise	Buy	$100→$120
Apr 29, 2024	Truist Securities	Tobey Sommer	PT Raise	Buy	$95→$100
Feb 2, 2024	Truist Securities	Tobey Sommer	PT Cut	Buy	$110→$95

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Neutral on Exponent, Lowers Price Target to $72

UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and lowers the price target from $75 to $72.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Exponent, Raises Price Target to $90

JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and raises the price target from $80 to $90.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Exponent, Lowers Price Target to $80

JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and lowers the price target from $95 to $80.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Exponent, Lowers Price Target to $75

UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and lowers the price target from $85 to $75.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Exponent, Lowers Price Target to $95

JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and lowers the price target from $100 to $95.

Benzinga Newsdesk

PRO
JP Morgan Initiates Coverage On Exponent with Overweight Rating, Announces Price Target of $100

JP Morgan analyst Tomohiko Sano initiates coverage on Exponent (NASDAQ:EXPO) with a Overweight rating and announces Price Target of $100.

Benzinga Newsdesk